Octave Bioscience

Provider of AI-based molecular diagnostic tools for neurodegenrative diseases

placeMenlo Park, California, United States calendar_todayFounded 2014 groups90 employees language octavebio.com

Social engagement

Social engagement: 30.3K social following, 8 posts in the last 12 months — below the industry typical range.

Investor mix

16 investors on record; lead investors include Novartis, Intermountain Ventures, BVF, Merck Global Health Innovation Fund.

Investor typeCountShare
Venture capital956%
Bank & private debt16%
Other / undisclosed638%

Recent activity

26 May 2026
Event
CMSC2026
26 May 2026
Leadership hire
Vice President, Business Development
22 May 2026
Event
webinar
Coming soon